... Study Table Incidence of Chronic GVHD in Children After AllogeneicStemCellTransplantation 10 The time range for evaluating chronic GVHD was from 100 days to years after transplantation, and incidence ... the greatest odds for chronic GVHD Peripheral blood stemcelltransplantation results in an increased risk for chronic GVHD compared with bone marrow transplantation Age at transplantation and ... chronic GVHD were acute GVHD, immune female donor to male recipient, and chronic myelogenous leukemiaChronic GVHD risk was lower after umbilical cord blood transplantation than bone marrow transplantation...
... patient’s pre- and post -transplantation (AML) cells and donor’s cells Polymorphism DNA repair mechanism Patient cells (pretransplantation) AML cells (posttransplantation) Donor cells XPA A23G NER ... of a secondary AML developing from donor-derived cells in a breast cancer patient who underwent allogeneicstemcelltransplantation Donor cellleukemia is a rare although well-recognized disease ... cancer Clin Cancer Res 2005, 11:1408-1415 Flynn CM, Kaufman DS: Donor cell leukemia: insight into cancer stem cells and the stemcell niche Blood 2007, 109:2688-2692 Xiao H, Shi J, Luo Y, Tan Y,...
... and the risk of hepatic venoocclusive disease in patients undergoing hematopoietic stemcell transplantation: a systematic review and meta-analysis Bone Marrow Transplant 2006, 37:677-686 Do you ... Vogelsang G, McDonald GB, Guinan EC: Multi-institutional use of defibrotide in 88 patients after stemcelltransplantation Page of (page number not for citation purposes) Journal of Medical Case Reports ... Defibotide has local antithrombotic and thrombolytic effects in the injured endothelium but lacks systemic Page of (page number not for citation purposes) Journal of Medical Case Reports 2009, 3:6164...
... Patterns of T -cell reconstitution by assessment of T -cell receptor excision circle and T -cell receptor clonal repertoire after allogeneic hematopoietic stemcelltransplantation in leukemia patients–a ... for adequate thymic function but impaired naive T -cell survival following allogeneic hematopoietic stemcelltransplantation in the absence of chronic graft-versus-host disease Blood 2003, 102:4600-7 ... Ho DD, Young JW: Direct evidence for new T -cell generation by patients after either T -cell- depleted or unmodified allogeneic hematopoietic stemcell transplantations Blood 2002, 100:2235-42 Poulin...
... and cell derivation of B cellchroniclymphocyticleukemia Curr Top Microbiol Immunol 2005, 294:31-49 Caligaris-Cappio F, Ghia P: The normal counterpart to the chroniclymphocyticleukemia B cell ... a signaling molecule in B -cell chroniclymphocyticleukemia cells Blood 2003, 102:2146-2155 Foster AE, Brenner MK, Dotti G: Adoptive T -cell immunotherapy of chroniclymphocytic leukaemia Best ... in chroniclymphocyticleukemia B cells J Immunol 2002, 169:6594-6603 Oppezzo P, Vuillier F, Vasconcelos Y, Dumas G, Magnac C, PayelleBrogard B, Pritsch O, Dighiero G: Chroniclymphocytic leukemia...
... H, Renges H, Fehse N, Waschke O, Fehse B, Kabisch H, et al: Allogeneic stem- celltransplantation in patients with refractory acute leukemia: a long-term follow-up Bone Marrow Transplant 2006, ... Longterm survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneicstemcelltransplantation Blood 2006, 108:1092-1099 ... blast cells in bone marrow (BM) was 26.0% (range; 0.2-100) before the start of chemotherapy for allo-HCT Six patients had leukemic involvement of the central nervous system (CNS) Stemcell sources...
... C: Transplantation of hematopoietic stem cells from alternate donors in acute myelogenous leukemiaLeukemia 2000, 14:502-504 Aversa F, Velardi A, Tabilio A, et al.: Haploidentical stemcelltransplantation ... engraftment after haploidentical stemcelltransplantationLeukemia 2004, 18:1835-1838 Passweg JR, Stern M, Koehl U, et al.: Use of natural killer cells in hematopoetic stemcelltransplantation Bone Marrow ... who relaspse after allogeneicstemcelltransplantation for chronic myeloid leukemia Blood 2000, 96:2712-2716 Porter DL, Collins RH Jr, Hardy C, et al.: Treatment ofrelapsed leukemia after unrelated...
... reduced-intensity conditioning for allogeneic 15 16 17 18 19 20 21 22 stem- cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic ... efficacy of an intermediate intensity conditioning regimen for allogeneicstemcelltransplantation in patients with high-risk acute myeloid leukemia in first complete remission Bone Marrow Transplant ... Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reducedintensity conditioning for allogeneicstemcelltransplantation Blood 2006, 108:1092-1099...
... CD20 chroniclymphocyticleukemia of the B -cell- lineage at primary diagnosis in 2002: 61.7% of gated lymImmunophenotype of expression Immunophenotype of chroniclymphocyticleukemia of the B -cell- lineage ... http://www.jmedicalcasereports.com/content/2/1/275 man ChronicLymphocyticLeukemia Study Group: Rituximab therapy of patients with B -cell chroniclymphocyticleukemia Blood 2001, 98(5):1326-1331 Srock S, ... Keating MJ: Rituximab dose-escalation trial in chroniclymphocyticleukemia J Clin Oncol 2001, 19(8):2165-2170 Conclusion Besides demonstrating the excellent response to rituximab in CLL, this case...
... Advances in Hematopoietic StemCell Gene Therapy 107 Toshihisa Tsuruta Section Clinical Aspects of StemCellTransplantation Chapter Progress in Hematopoietic StemCellTransplantation 139 Miroslaw ... related to stem cells and Cell Transplantation, we felt it was important to take this opportunity to share these new develop‐ ments and innovations describing stemcell research in the celltransplantation ... investigating the role of stem cells in celltransplantation or regenerative medicine increased remarkably across all sections of the stemcell related journals The largest number of stemcell articles was...
... induced pluripotent stem cells Stem Cells 27, 1042-1049 18 New Advances in StemCellTransplantation Cho, M.K., McGee, G., and Magnus, D (2006) Research conduct Lessons of the stemcell scandal Science ... remain a stem cell, or become another type of cell with a more specialized function, such as a muscle cell, a red blood cell, or a brain cell Because of the unique abilities of stem cells, as ... investigating the role of stem cells in celltransplantation or regenerative medicine increased remarkably across all sections of the stemcell related journals The largest number of stemcell articles was...
... in B -cell chroniclymphocyticleukemia Cytometry B Clin Cytom 2008, 74:40-44 Bakke AC, Purtzer Z, Leis J, Huang J: A robust ratio metric method for analysis of Zap-70 expression in chroniclymphocytic ... TJ: Guidelines for the diagnosis and treatment of chroniclymphocytic leukemia: a report from the International Workshop on ChronicLymphocyticLeukemia updating the National Cancer Institute-Working ... in chroniclymphocyticleukemia and immunocytoma Leuk Lymphoma 1996, 22:439-447 Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS: Clinical staging of chroniclymphocytic leukemia...
... thymicnaive Th cells *Abbreviations: IQR, Interquartile range; Th cells, T helper cells; Treg, regulatory T cells; TEM, effector memory T cells; TCM, central memory T cells; CTL, cytotoxic T cells Motta ... NK-cells in a consecutive series of newly diagnosed patients with chroniclymphocytic leukaemia Br J Haematol 2008, 141:607-614 Dearden C: Disease-specific complications of chroniclymphocyticleukemia ... Turner V, Handgretinger R: Prediction of T -cell reconstitution by assessment of T -cell receptor excision circle before allogeneic hematopoietic stemcelltransplantation in pediatric patients Blood...
... Selected Topics in ChronicLymphocyticLeukemia Pathogenesis of CLL, and they also distinguish CLL from other disorders such as prolymphocytic leukemia, hairy -cell leukemia, mantle -cell lymphoma and ... B -cell chroniclymphocyticleukemia Blood 99, 4116–4121 [35] Klein U., et al (2010) The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chroniclymphocyticleukemia ... genotype in B cellchroniclymphocyticleukemia J Exp Med 194, 1639– 1647 14 ChronicLymphocyticLeukemia [51] Klein U et al (1998) Somatic hypermutation in normal and transformed human B cells Immunol...
... systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem- cell transplantation: a phase I study Lancet 2000, 356: 701-707 Traynor A, Burt RK: Haematopoietic stemcelltransplantation ... without stemcell support Competing interests None declared References 10 11 12 13 14 Marmont AM, van Lint MT, Gualandi F, Bacigalupo A: Autologous marrow stemcelltransplantation for severe systemic ... with the same dose of cyclophosphamide without hematopoietic stemcell support, and also to hasten stemcell regeneration of the immune system under the umbrella of the ATG effect Based on the same...
... hematopoietic stemcelltransplantation Hematopoietic stemcelltransplantation (HSCT) is a complex multistep procedure involving mobilisation and harvesting of hematopoietic stem cells (HSCs) ... showing increases in T -cell receptor excision circles and CD31+ T cells and normalisation of new T -cell receptor repertoires [53,54] Allogeneic hematopoietic stemcelltransplantation The interaction ... Autologous stemcelltransplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry Ann Rheum Dis 2004, 63:974-981 Tyndall A, Saccardi R: Haematopoietic stemcell transplantation...